ENDOMETRIYNI BEZLI-KISTOZ GIPERPLAZIYASINING MOLEKULAR-GENETIK JIHATLARI
Abdulatipova F. A.
Annotatsiya
Endometriyning bezli kistoz giperplaziyasi ko‘pincha estrogen ta’sirining progesteron bilan muvozanatlanmasligi fonida rivojlanadigan proliferativ jarayon bo‘lib, zamonaviy tasniflarda u, odatda, “atipiyasiz endometriyal giperplaziya” guruhiga yaqin tushuncha sifatida ko‘riladi. Ushbu maqolada bez va stroma nisbatining o‘zgarishi bilan kechadigan morfologik belgilarning molekular asoslari, erta klonal o‘zgarishlar, PI3K–AKT signal yo‘li buzilishlari, o‘sishni cheklovchi genlar faoliyatining susayishi, hamda immunogistokimyoviy markerlarning diagnostik qiymati muhokama qilinadi. Ayni paytda “molekular marker topildi, demak hammasi hal” degan soddalashtirishdan qochiladi: amaliyotda molekular belgilar ko‘proq differensial diagnostika va xavfni stratifikatsiya qilishga xizmat qiladi, klinik qaror esa morfologiya, simptomatika va kuzatuv imkoniyatlari bilan birgalikda qabul qilinadi.
Adabiyotlar
- Royal College of Obstetricians and Gynaecologists; British Society for Gynaecological Endoscopy. Management of Endometrial Hyperplasia. Green-top Guideline No. 67. London, 2016. 31 p.
- WHO Classification framework (IGCS pathology resource). 2020 WHO Classification of Tumors of the Uterine Corpus (selected educational material). 2020. Electronic resource.
- Sobczuk K., Sobczuk A. New classification system of endometrial hyperplasia WHO 2014 and its clinical implications. Przegląd Menopauzalny, 2017. Electronic resource.
- Berg A., et al. Molecular profiling of endometrial carcinoma precursor lesions. Oncotarget, 2014. Electronic resource.
- Allison K. H., et al. PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia. International Journal of Gynecological Pathology, 2012. Electronic resource.